Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Endo Health Solutions Inc    ENDP

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Senate Panel Seeks Info From J&J, Endo, Others Over Concern On Painkiller Marketing -Reuters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/09/2012 | 08:44pm CET

The Senate Finance Committee is looking into possible links between three drug companies and nonprofit medical groups, citing concerns about the groups' advocacy of painkillers, Reuters reported Wednesday.

The panel sent letters to Johnson & Johnson (JNJ), Endo Pharmaceuticals Holdings Inc. (>> Endo Pharmaceuticals Holdings Inc) and Purdue Pharma LP and seven medical groups seeking documents about their financial connections, Reuters reported.

Sen. Max Baucus (D., Mont.), the committee's chairman, said in a statement that "painkillers have an important role in health care when prescribed and used properly, but pushing misinformation on consumers to boost profits is not only wrong, it's dangerous," Reuters reported.

Reuters said officials at the three drug companies weren't immediately available for comment.

Full story at http://www.reuters.com/article/2012/05/09/us-usa-painkillers-investigation-idUSBRE84811420120509

-Dow Jones Newswires; 212-416-2900

Stocks mentioned in the article : Endo Pharmaceuticals Holdings Inc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ENDO HEALTH SOLUTIONS INC
12/14 ENDO INTERNATIONAL PLC : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC ..
12/11 ENDO INTERNATIONAL PLC : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of..
12/10 ENDO INTERNATIONAL PLC : Pomerantz Law Firm Reminds Shareholders with Losses on ..
12/05 ENDO INTERNATIONAL PLC : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of..
12/01 ENDO INTERNATIONAL PLC : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC ..
11/29 ENDO INTERNATIONAL PLC : ENDO INTERNATIONAL Faruqi & Faruqi, LLP Encourages Inve..
11/25 ENDO INTERNATIONAL PLC : Pomerantz Law Firm Reminds Shareholders with Losses on ..
11/10 ENDO INTERNATIONAL PLC : Today’s Research Reports on Trending Tickers: Endo Inte..
11/09 ENDO INTERNATIONAL PLC : to Host Earnings Call
10/17 Amneal, Impax combine to tackle generic drug pricing pressure
More news
Financials ($)
Sales 2017 3 458 M
EBIT 2017 1 425 M
Net income 2017 -1 062 M
Debt 2017 7 442 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018 31,24
EV / Sales 2017 2,66x
EV / Sales 2018 2,89x
Capitalization 1 744 M
Technical analysis trends ENDO HEALTH SOLUTIONS INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 22
Average target price 10,3 $
Spread / Average Target 32%
EPS Revisions
Managers
NameTitle
Paul V. Campanelli President, Chief Executive Officer & Director
Roger H. Kimmel Chairman
Terrance J. Coughlin Chief Operating Officer & Executive Vice President
Blaise Coleman Chief Financial Officer & Executive Vice President
Robert J. Cobuzzi SVP-Operations, Research & Development Strategy